Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ronnie Neuberg (NPI 1457328932)

Field	Value
Entity Type	Individual
Organization	Ronnie Neuberg
Address	112 Saluda Ridge Ct Ste 200
City	West Columbia
State	SC
ZIP	29169
Taxonomy	Pediatrics Physician
NPI Enumerated	March 3, 2006

Payer Source	Total Paid
Medicare	$2.7M
Medicaid	$0

Key Findings

This provider has a long-tenured NPI (enumerated on 2006-03-03 (~20 years ago)) and a Medicare-dominant revenue profile, with lifetime Medicare revenue of $2.7M and no Medicaid billing on file. The absence of any Medicaid revenue makes this effectively a single-payer (Medicare) billing footprint, concentrating payment risk and market exposure to Medicare policy changes.

Revenue is heavily concentrated in a small set of biologic drug codes: the precomputed top three Medicare codes account for 53.5% of total Medicare revenue, led by J2350 ($579.6K, 21.4%), J3245 ($440K, 16.2%), and J0897 ($432K, 15.9%). This concentration indicates that a majority of the practice’s Medicare dollars are driven by a few high-cost injectable therapies rather than broad E/M visit volume.

The code mix shows an infusion- and biologic-focused operation: large revenues on J2350 (ocrelizumab), J3245 (tildrakizumab), J3380 (vedolizumab), J0897 (denosumab) and frequent use of infusion/administration codes such as 96365, 96366, 96372 and 96375. These patterns are consistent with an office-based infusion suite or outpatient infusion service that administers monoclonal antibodies and other specialty injectables rather than a visit-centric ambulatory practice.

Several codes place this provider well above typical national volumes for specific services: J0897 is labeled an “extreme outlier” (ranks #176 of 10057, 98th percentile), while administration/infusion codes such as 96365 and 96372 and the E/M code 99202 are described as notably or extremely above typical national volume (all reported at high percentiles). These percentile labels signal that for certain infused drugs and administration encounters the provider is a major outlier and should be considered a high-volume national participant for those specific services.

For some specialized drugs the provider is prominent within a small national peer set: J0485 (belatacept) ranks #2 of 20 providers nationally (95th percentile), which suggests a leading role among the limited number of providers billing that drug even if the overall national sample is small. Conversely, codes like J2350 and J3245 are described as typical, unremarkable volume relative to national peers, indicating the practice is selective in which biologics it dominates.

There are anomalous billing signals that merit follow-up: Q0138 shows 10.2K claims with $0 avg paid/claim and $0 revenue despite a non-trivial rank (1043 of 1238, 14th percentile), which is unusual for a high claim count. This pattern—large claim volumes with zero reported revenue—warrants a closer look at billing configurations, bundling, or administrative coding conventions for that code.

The clinical-service implications are operationally significant: a business model centered on high-cost injectables and infusions (as shown by the top drug codes and frequent infusion CPTs) implies dependence on drug supply, buy-and-bill margins, and payer coverage decisions. With 53.5% of Medicare revenue tied to the top three codes, utilization or reimbursement changes for those agents could materially impact the provider’s revenue stream.

There is a potential mismatch between listed taxonomy (Pediatrics Physician) and the adult specialty biologic mix billed here; the dataset shows extensive adult-focused biologic and infusion activity. This could reflect a broad service offering, a shared practice/group arrangement, or an outdated taxonomy on file—each of which has different operational and credentialing implications and should be validated in downstream due diligence.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

23 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	12,600	$50	$579.6K
J3245	Injection, tildrakizumab, 1 mg	4,000	$110	$440K
J0897	Injection, denosumab, 1 mg	24,000	$20	$432K
J3380	Injection, vedolizumab, intravenous, 1 mg	22,800	$20	$387.6K
J0485	Injection, belatacept, 1 mg	88,750	$1	$266.3K
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	6,340	$30	$183.9K
J3111	Injection, romosozumab-aqqg, 1 mg	21,420	$10	$171.4K
J3032	Injection, eptinezumab-jjmr, 1 mg	8,900	$10	$97.9K
J1306	Injection, inclisiran, 1 mg	8,800	$10	$79.2K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	870	$40	$38.3K

Showing 1–10 of 23

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 23 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Ronnie Neuberg — 5 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

23 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	3	10	10,800	$40	$546.8K
J3245	8	20	3,800	$110	$435.3K
J0485	1	10	88,750	$1	$262.7K
J3380	3	20	11,400	$20	$231K
J1561	2	10	3,890	$40	$146.6K
J3111	8	40	12,390	$10	$129.4K
J3032	3	10	9,000	$10	$113.9K
J1306	10	20	8,800	$10	$95.1K
J0897	7	250	2,400	$20	$91.2K
96413	85	150	140	$90	$22.1K

Showing 1–10 of 23

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ronnie Neuberg, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Prisma Health University Medical Group	SC	Family Medicine Physician	$0	$171.7M
Prisma Health Medical Group-midlands	SC	Multi-Specialty Clinic/Center	$0	$77.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$74.6M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$68.3M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$28.1M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$11.8M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$7.4M
Prisma Health-midlands	SC	General Acute Care Hospital	$0	$6.9M
Prisma Health Tuomey	SC	Emergency Medicine Physician	$0	$6.8M
Prisma Health-midlands	SC	Emergency Medicine Physician	$0	$6.8M

Nearby Providers

Other providers in the same ZIP code as Ronnie Neuberg, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Palmetto Infusion Services LLC	SC	Infusion Therapy Clinic/Center	$0	$93.6M
Lexington Health Inc	SC	General Acute Care Hospital	$0	$27.4M
Lexington County Health Services District Inc	SC	General Acute Care Hospital	$0	$19.2M
United Cerebral Palsy Of South Carolina, Inc	SC	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$15.7M
Palmetto Retina Center LLC	SC	Ophthalmology Physician	$0	$10.6M
Lexington Health Inc	SC	Emergency Medicine Physician	$0	$4.2M
Karen Park Family Dentistry, P.A.	SC	Dentist	$0	$4.2M
Lexington County Health Serv	SC	General Acute Care Hospital	$0	$4M
John Payne	SC	Ophthalmology Physician	$4M	$0
Steven Madden	SC	Hematology & Oncology Physician	$4M	$0

Ronnie Neuberg — Billing Profile & Reimbursement Data

Sign up for Ronnie Neuberg — Billing Profile & Reimbursement Data policy alerts

Ronnie Neuberg — Billing Profile & Reimbursement Data

Sign up for Ronnie Neuberg — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References